• February 14, 2024

The AAAAI is encouraging widespread and routine penicillin allergy evaluations for patients who have the allergy listed in their medical records but who are not truly allergic or have outgrown the allergy. Such evaluations demonstrate the overwhelming majority of patients tolerate penicillins so the allergy label can be removed and the patient can be delabeled. […]

  • December 1, 2023

The relationship between RSV infection in infancy and development of childhood asthma has been unclear. Now a study has examined the effects of RSV infections of all different severities on childhood asthma risk at a population level. The findings showed an age-dependent association between RSV infection during infancy and childhood asthma. The link is explained […]

  • October 17, 2023

The United States National Environmental Education Foundation (NEEF) and Hip Hop Public Health (HHPH) have collaborated to develop and launch a free multimedia collection called EMPOWER. Consisting of eight original songs, animated videos and printable educational materials, EMPOWER “aims to inspire young people with asthma to take charge of their health with evidence-based, self-management skills.” […]

  • August 9, 2023

An inflammatory molecule called LIGHT appears to be the cause of tissue remodeling and life-threatening airway damage in patients with severe asthma, according to scientists from the La Jolla Institute for Immunology (LJI). Findings suggest that LIGHT plays a dominant role and coordinates the tissue remodeling process. Moreover, the study is “the first to show […]

  • June 13, 2023

A grant from the United States Environmental Protection Agency (EPA) is supporting Breath SMART (Safety Monitoring Air ‘Round Town). The program will create a community-based network of air quality monitors in Milwaukee, Wisconsin neighborhoods with the highest rates of hospitalizations and emergency room visits related to asthma. Monitors will be installed at approximately 15 schools […]

A new United States law recognizing sesame as the ninth major food allergen is having unintended consequences. Some food manufacturers and commercial bakeries that support restaurants, stock grocery shelves and supply schools are intentionally adding sesame to various products that previously did not contain it. Consequently, this decreases the number of sesame-free products available for […]

  • February 11, 2023

Following “lower than expected demand,” Nestlé is exploring strategic options for Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp], the first and only drug approved by the US FDA for the treatment of peanut allergy in children. Possible causes for the slow uptake of Palforzia include the COVID-19 pandemic, frequent doctor’s visits with additional time when escalating […]

Excipient enhanced growth (EEG) is progressing through toxicological studies and showing promise for treatment of asthma and lung cancer by delivering active molecules to target sites in the lungs. This article discusses development of two candidates, budesonide and gemcitabine, for local lung delivery using this formulation approach in combination with traditional spray drying for the […]

  • December 5, 2022

The United States Centers for Disease Control and Prevention (CDC) has published a report in the Annals of Allergy, Asthma and Immunology that offers recommendations and resources to assist allergists and immunologists in supporting patients as they become affected by climate change. In two articles, Healio interviewed two of the three report authors. They discuss […]

  • October 14, 2022

The SABINA study of SABA inhaler usage and risk of asthma exacerbations, funded by AstraZeneca, is the largest real-world observational data analysis of asthma inhaler therapy and has evaluated more than one million patients across 40 countries. In addition, at Queen Mary University of London, a study of more than 700,000 patient records evaluated SABA […]